Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2025-12-25 @ 2:37 AM
NCT ID:
NCT03479034
Eligibility Criteria:
Inclusion Criteria:
* Ages 18-85
* Cognitively able to understand instructions and care for themselves
* Lives in the community (not institutionalised)
* Owner of a smartphone and able to use Apps
* On 3 or more chronic prescription medications
* Informed consent as documented by signature (Appendix Informed Consent Form)
* Has had experience with prescriptions in Australia for at least 1 year
* For the clinicians - any clinician who is using the ScalaMed prescription system in the Holdsworth House
* For pharmacists - who are utilising the ScalaMed system in one of the four clinics
Exclusion Criteria:
* Known or suspected non-compliance, drug or alcohol abuse
* Inability to follow the procedures of the study due to language problems, psychological disorders, dementia of the participant
* Previous enrolment into the current study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT03479034
Study Brief:
Protocol Section:
NCT03479034